Afexa Life Sciences Inc. (FXA) - Financial and Strategic SWOT Analysis Review

Afexa Life Sciences Inc. (ALSI, formerly known as CV Technologies Inc.) is a health sciences and technology company. The company is principally engaged in providing natural health products for health maintenance and to prevent diseases. The company is also focused on the development of natural based health products. The company's products include COLD-fX for the prevention and treatment of cold and flu infections by strengthening the body's immune system; CELL-fX, which helps relieve the symptoms of bone and joint pain, and formation of connective tissue; and REMEMBER-fX that enhances memory and mental alertness. The proprietary technology of the company is ChemBioPrint, which is used to formulate and standardize natural health products that have proven health benefits. The operations of the company are spanned across Canada with its branch offices located in Montreal and Toronto. ALSI is headquartered at Edmonton in Alberta, Canada.

Afexa Life Sciences Inc. Key Recent Developments

Aug 13, 2010: Afexa Reports Net Loss Of $4.1 Million For Q1 Fiscal 2011

Jan 21, 2011: Afexa Appoints Tracey Ramsay as Chief Marketing Officer And Senior Vice President Sales
Jun 24, 2010: Afexa Reports Net Loss Of $4 Million For Three Month Fiscal Year Ended March 31, 2010

This comprehensive SWOT profile of Afexa Life Sciences Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Afexa Life Sciences Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Report Highlights
Synovics Pharmaceuticals, Inc.
Blairex Laboratories, Inc.
EMD Serono, Inc.
Gene Smart Health
Intradigm Corporation
Ikaria Inc.